ABT Abbott Laboratories Common Stock

NYSE · US · Healthcare · Medical Devices · abbott.com

100.48USD+3.05%Mkt Cap: 169.83B $P/E: 31.55Today

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nu…

Industry Peers

Medical Devices

Screen all

MDT

Medtronic plc. Ordinary Shares

$110.49BUSDP/E 21.2

SYK

Stryker Corporation Common Stock

$105.65BUSDP/E 28.5

BSX

Boston Scientific Corporation Common Stock

$61.74BUSDP/E 17.2

Edwards Lifesciences Corporation Common Stock

$49.03BUSDP/E 50.7

SHL

Siemens Healthineers AG

$46.06BUSDP/E 19.2

DXCM

DexCom, Inc. - Common Stock

$32.21BUSDP/E 33.7

GEHC

GE HealthCare Technologies Inc. - Common Stock

$29.24BUSDP/E 14.8

PHG

Koninklijke Philips N.V. NY Registry Shares

$23.38BUSDP/E 18.5

PHIA

Koninklijke Philips N.V.

$22.60BUSDP/E 18.7

STE

STERIS plc (Ireland) Ordinary Shares

Zimmer Biomet Holdings, Inc. Common Stock

$16.84BUSDP/E 21.4

PEN

Penumbra, Inc. Common Stock

$12.51BUSDP/E 77.8

TXG

10x Genomics, Inc. - Common Stock

$12.18BUSD

SNN

Smith & Nephew SNATS, Inc. Common Stock

Globus Medical, Inc. Class A Common Stock

Bio-Rad Laboratories, Inc. Class A Common Stock

$9.88BUSDP/E 45.0

GKOS

Glaukos Corporation Common Stock

$9.66BUSD

Key Statistics

Company

Market Cap169.83B USD

Enterprise Value196.48B USD

Revenue (TTM)46.58B USD

Gross Profit25.01B USD

Net Income (TTM)6.52B USD

Revenue/Share26.76 USD

Last Price100.48 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees122.0K

CountryUS

SectorHealthcare

IndustryMedical Devices

ISIN—

Valuation

P/E (Trailing)31.55

P/E (Forward)16.07

PEG1.79

EV/EBITDA16.82

EV/Revenue4.22

P/S3.65

P/B3.30

EPS (TTM)3.10

EPS (Forward)6.07

52W Range

81.9733% of range137.49

52W High137.49 USD

52W Low81.97 USD

Profitability

Gross Margin56.42%

Oper. Margin14.71%

EBITDA Margin25.07%

Profit Margin14.72%

ROE12.51%

ROA7.52%

Growth

Revenue Growth13.00%

Earnings Growth-47.50%

Cash Flow & Leverage

Operating CF9.57B USD

CapEx (TTM)2.17B USD

FCF Margin15.48%

FCF Yield4.24%

Net Debt27.12B USD

Net Debt/EBITDA2.32

Balance Sheet

Debt/Equity0.27

Current Ratio1.38

Quick Ratio0.80

Book Value/Sh29.54 USD

Cash/Share3.24 USD

Dividends

Fwd Div Rate2.52 USD

Trail. Div Rate2.48 USD

Div. Yield2.58%

5Y Avg Yield1.84%

Payout Ratio78.71%

Ex-Div DateOct 15, 2026

Pay DateNov 16, 2026

Splits

Last Split10000:4798

Split DateJan 2, 2013

Analyst Consensus

Rating1.4 (Strong Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)120.58 USD

Upside (mean)+20.0%

Target Range103.00 USD – 135.00 USD

103.00+20.0% to mean135.00

# Analysts25

Ownership

Shares Out.1.74B

Float1.72B

Insiders0.49%

Institutions81.79%

Short Interest

Short Ratio2.5d

Short % Float1.29%

Short % Out.1.15%

Shares Short19.91M

Short (prev mo.)20.38M

Technical

SMA 50106.84 (-6.0%)

SMA 200104.01 (-3.4%)

Beta0.59

S&P 52W Chg14.58%

Avg Vol (30d)8.03M

Avg Vol (10d)7.96M

Technical Indicators

RSI (14)31.1

MACD-2.1909

MACD Signal-1.5869

MACD Hist.-0.6040

BB Upper107.51 USD

BB Middle102.21 USD

BB Lower96.91 USD

BB Width10.38%

ATR (14)2.331 USD

Vol Ratio (20d)0.78x